Management , Share Holder Communications, page-56

For once we can agree to a point and that being one needs to be in for the long term but having said that its the BOD that have given share holders an unrealistic expectations by putting out spin.
The fact they said they were confident in Elanco taking up the deal when in fact they knew or shouldn't have known it was the case.
The fact that they on a number of occasions stated they had overcome the taste concerns back in 2016 when in fact they hadn't.
The fact that on the 18 June they stated the next step was to develop a Executive Summary, this was again stated on 24 June when in fact they knew further trials where needed.
The fact that even today they do not have a MPL table for human trials they themselves are happy with.
The fact that only 6 dogs could be recruited across 4 sites for canine trials.

So until they actually do in human phase 11 trials for cancer and in human trials for covid to me anything they put out is spin, telling us they are in discussions doesn't cut the mustard any more.
Its time for action, its time to get approval for covid and get on with the trial.

IMO very little will be said about K9 cancer any more they had one chance and they blew it.